ROMAN; Richard J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ROMAN; Richard J..The latest application filed is for "method and composition for reversing cognitive impairments and loss using sglt2 inhibitors".

Company Profile

1.10.17

ROMAN; Richard J. - Jackson MS
Roman; Richard J. - Brookfield WI
Roman; Richard J. - Brandon MS
Roman, Richard J - Brookfield WI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method And Composition For Reversing Cognitive Impairments And Loss Using Sglt2 Inhibitors App 20210059984 - FAN; Fan ; et al.	2021-03-04
Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases Grant 9,511,072 - Sweeney , et al. December 6, 2	2016-12-06
Combinations of SGLT 2 inhibitors and antihypertensive drugs Grant 9,320,727 - Kojima , et al. April 26, 2	2016-04-26
Combinations Of Sglt 2 Inhibitors And Antihypertensive Drugs App 20150320721 - KOJIMA; Naoki ; et al.	2015-11-12
Methods of Modulating Cell Proliferation and Cyst Formation in Polycystic Kidney and Liver Diseases App 20140329811 - Sweeney; William E. ; et al.	2014-11-06
Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases Grant 8,846,764 - Sweeney , et al. September 30, 2	2014-09-30
Compositions for the Treatment and Prevention of Nephropathy App 20090203603 - Baron; Alain ; et al.	2009-08-13
Rat model of diabetic nephropathy Grant 7,507,871 - Jacob , et al. March 24, 2	2009-03-24
Method For Treating Renal Disease App 20080306155 - Roman; Richard J. ; et al.	2008-12-11
Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases App 20080167382 - Sweeney; William E. ; et al.	2008-07-10
Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular disease Grant 7,307,101 - Roman , et al. December 11, 2	2007-12-11
Method for treating renal disease App 20070004802 - Roman; Richard J. ; et al.	2007-01-04
Method for treating renal disease App 20060063836 - Roman; Richard J. ; et al.	2006-03-23
Rat model of diabetic nephropathy App 20050166273 - Jacob, Howard J. ; et al.	2005-07-28
Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular disease App 20050153871 - Roman, Richard J ; et al.	2005-07-14
Methods of modulating angiogenesis and cancer cell proliferation App 20050124618 - Roman, Richard J. ; et al.	2005-06-09
Compositions for the treatment and prevention of nephropathy App 20040209803 - Baron, Alain ; et al.	2004-10-21
Fluorescent hplc assay for 20-hete and other p-450 metabolites of arachidonic acid Grant 6,764,855 - Roman , et al. July 20, 2	2004-07-20
Methods and compositions for pharmacological and toxicological evaluation of test agents App 20030237103 - Jacob, Howard J. ; et al.	2003-12-25
Fluorescent hplc assay for 20-hete and other p-450 metabolites of arachidonic acid App 20030211623 - Roman, Richard J ; et al.	2003-11-13
20-HETE antagonists and agonists Grant 6,605,641 - Roman , et al. August 12, 2	2003-08-12
20-Hete antagonists and agonists Grant 6,596,769 - Roman , et al. July 22, 2	2003-07-22
20- Hete antagonists and agonists App 20020072534 - Roman, Richard J. ; et al.	2002-06-13
20-HETE antagonists and agonists App 20020049244 - Roman, Richard J. ; et al.	2002-04-25

Company Registrations

NCAGE Code	48BA9	ROMAN RICHARD J
CAGE Code	48BA9	ROMAN, RICHARD J
DUNS	612920582	ROMAN, RICHARD J

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.